Compare Decibel Cannabis Co., Inc. with Similar Stocks
Stock DNA
Pharmaceuticals & Biotechnology
CAD 61 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
0.51
-6.48%
0.95
Revenue and Profits:
Net Sales:
30 Million
(Quarterly Results - Jun 2025)
Net Profit:
2 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-34.48%
0%
-34.48%
6 Months
0%
0%
0.0%
1 Year
35.71%
0%
35.71%
2 Years
-29.63%
0%
-29.63%
3 Years
-24.0%
0%
-24.0%
4 Years
-29.63%
0%
-29.63%
5 Years
-45.71%
0%
-45.71%
Decibel Cannabis Co., Inc. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
40.49%
EBIT Growth (5y)
-10.62%
EBIT to Interest (avg)
-4.22
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0.56
Sales to Capital Employed (avg)
1.09
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.01%
ROCE (avg)
0
ROE (avg)
0.27%
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
1.20
EV to EBIT
-9.31
EV to EBITDA
-18.39
EV to Capital Employed
1.13
EV to Sales
1.11
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-12.18%
ROE (Latest)
-0.07%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Bullish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
Shareholding Snapshot : Sep 2025
Shareholding Compare (%holding) 
Majority shareholders
Foreign Institutions
Domestic Funds
Held in 0 Schemes (0%)
Foreign Institutions
Held by 1 Foreign Institutions (0.01%)
Strategic Entities with highest holding
Highest Public shareholder
Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY
Jun'25
Jun'24
Change(%)
Net Sales
29.80
22.20
34.23%
Operating Profit (PBDIT) excl Other Income
-2.10
-1.10
-90.91%
Interest
0.70
0.80
-12.50%
Exceptional Items
5.70
3.20
78.12%
Consolidate Net Profit
1.60
0.10
1,500.00%
Operating Profit Margin (Excl OI)
-124.70%
-101.60%
-2.31%
USD in Million.
Net Sales
YoY Growth in quarter ended Jun 2025 is 34.23% vs -22.11% in Jun 2024
Consolidated Net Profit
YoY Growth in quarter ended Jun 2025 is 1,500.00% vs 120.00% in Jun 2024
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
92.50
116.00
-20.26%
Operating Profit (PBDIT) excl Other Income
-3.70
-5.50
32.73%
Interest
2.90
2.90
Exceptional Items
10.70
10.00
7.00%
Consolidate Net Profit
13.60
-1.80
855.56%
Operating Profit Margin (Excl OI)
-93.90%
-73.90%
-2.00%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is -20.26% vs 46.28% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is 855.56% vs 60.00% in Dec 2023
About Decibel Cannabis Co., Inc. 
Decibel Cannabis Co., Inc.
Pharmaceuticals & Biotechnology
Decibel Cannabis Company Inc., formerly Westleaf Inc, is a Canada-based vertically integrated cannabis company. The Company has assets across the cannabis value chain, with an emphasis on engaging cannabis retail and product brands. The Company invests in building its manufacturing facilities. It is an owner of several brands, such as Qwest, Prairie Records and BlendCraft. Prairie Records is a retail concept that merges recreational cannabis and music. The Qwest brand provides Wonder Qwest, Zest Qwest, Vision Qwest, Ice Qwest and Spirit Qwest. BlendCraft is created using only flower and trichome-coated sugar leaf from Qwest’s collection of cultivars.
Company Coordinates 
Company Details
1000, 517-10Th Avenue Sw , CALGARY AB : T2R 0A8
Registrar Details






